We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRML:NASDAQCritical Metals Corp. Analysis

Data as of 2026-06-20 - not real-time

$10.15

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Critical Metals Corp. (CRML) trades at $10.15, notably below its DCF-derived fair value of $13.31, implying a potential upside of roughly 30% and an overall upside/ downside metric of 67% according to the model. Technical indicators are neutral‑to‑bearish: the 20‑day SMA (10.64) sits below the 50‑day SMA (11.06), MACD is in a bearish configuration, RSI is at 47 and volume is on a decreasing trend, with the price hovering just above the $9 support level. Risk metrics are elevated, highlighted by a 30‑day volatility of 87% and a computed beta of 3.87, underscoring sensitivity to market swings.
Fundamentally, CRML exhibits strong top‑line momentum with 58% revenue growth, a robust cash pile of $80.9 M versus modest debt of $2.4 M, and a recent 15‑year offtake agreement with REalloys for rare‑earth concentrate. However, the company remains loss‑making with negative operating margins and zero EPS, and its free cash flow is positive only due to a large cash balance. The rare‑earth exposure and strategic agreements provide a compelling long‑term catalyst, but execution risk and high volatility keep the near‑term outlook cautious.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Bearish technical crossover (20‑day SMA below 50‑day SMA)
  • Decreasing volume and high short‑term volatility
  • Proximity to $9 support level with limited immediate catalyst

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • 15‑year offtake agreement securing future revenue streams
  • Undervalued price relative to DCF fair value
  • Strong cash position supporting continued exploration

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic exposure to growing rare‑earth and lithium markets
  • Potential upside of ~30%+ if DCF assumptions materialize
  • Long‑term demand tailwinds from clean‑energy and defense sectors

Key Metrics & Analysis

Financial Health

Revenue Growth57.80%
P/E Ratio-53.4
ROE-140.98%
ROA-15.65%
Debt/Equity1.65
P/B Ratio8.6
Op. Cash Flow$-31071168
Free Cash Flow$52.1M

Technical Analysis

TrendNeutral
RSI47.0
Support$9.00
Resistance$12.60
MA 20$10.64
MA 50$11.06
MA 200$10.61
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Fair Value$13.31
Target Price$17.00
Upside/Downside67.49%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta3.87
Volatility87.02%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.